Literature DB >> 23384325

Trends in the prevalence, risk and pregnancy outcome of multiple births with congenital anomaly: a registry-based study in 14 European countries 1984-2007.

B Boyle1, R McConkey, E Garne, M Loane, M C Addor, M K Bakker, P A Boyd, M Gatt, R Greenlees, M Haeusler, K Klungsøyr, A Latos-Bielenska, N Lelong, R McDonnell, J Métneki, C Mullaney, V Nelen, M O'Mahony, A Pierini, J Rankin, A Rissmann, D Tucker, D Wellesley, H Dolk.   

Abstract

OBJECTIVE: To assess the public health consequences of the rise in multiple births with respect to congenital anomalies.
DESIGN: Descriptive epidemiological analysis of data from population-based congenital anomaly registries.
SETTING: Fourteen European countries. POPULATION: A total of 5.4 million births 1984-2007, of which 3% were multiple births.
METHODS: Cases of congenital anomaly included live births, fetal deaths from 20 weeks of gestation and terminations of pregnancy for fetal anomaly. MAIN OUTCOME MEASURES: Prevalence rates per 10,000 births and relative risk of congenital anomaly in multiple versus singleton births (1984-2007); proportion prenatally diagnosed, proportion by pregnancy outcome (2000-07). Proportion of pairs where both co-twins were cases.
RESULTS: Prevalence of congenital anomalies from multiple births increased from 5.9 (1984-87) to 10.7 per 10,000 births (2004-07). Relative risk of nonchromosomal anomaly in multiple births was 1.35 (95% CI 1.31-1.39), increasing over time, and of chromosomal anomalies was 0.72 (95% CI 0.65-0.80), decreasing over time. In 11.4% of affected twin pairs both babies had congenital anomalies (2000-07). The prenatal diagnosis rate was similar for multiple and singleton pregnancies. Cases from multiple pregnancies were less likely to be terminations of pregnancy for fetal anomaly, odds ratio 0.41 (95% CI 0.35-0.48) and more likely to be stillbirths and neonatal deaths.
CONCLUSIONS: The increase in babies who are both from a multiple pregnancy and affected by a congenital anomaly has implications for prenatal and postnatal service provision. The contribution of assisted reproductive technologies to the increase in risk needs further research. The deficit of chromosomal anomalies among multiple births has relevance for prenatal risk counselling.
© 2013 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2013 RCOG.

Entities:  

Mesh:

Year:  2013        PMID: 23384325     DOI: 10.1111/1471-0528.12146

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  16 in total

Review 1.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Natalie Bello; Iliana S Hurtado Rendon; Zoltan Arany
Journal:  J Am Coll Cardiol       Date:  2013-09-04       Impact factor: 24.094

2.  Meckel-Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in Europe.

Authors:  Ingeborg Barisic; Ljubica Boban; Maria Loane; Ester Garne; Diana Wellesley; Elisa Calzolari; Helen Dolk; Marie-Claude Addor; Jorieke Eh Bergman; Paula Braz; Elizabeth S Draper; Martin Haeusler; Babak Khoshnood; Kari Klungsoyr; Anna Pierini; Annette Queisser-Luft; Judith Rankin; Anke Rissmann; Christine Verellen-Dumoulin
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

3.  Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in Europe.

Authors:  Ingeborg Barisic; Ljubica Odak; Maria Loane; Ester Garne; Diana Wellesley; Elisa Calzolari; Helen Dolk; Marie-Claude Addor; Larraitz Arriola; Jorieke Bergman; Sebastiano Bianca; Berenice Doray; Babak Khoshnood; Kari Klungsoyr; Bob McDonnell; Anna Pierini; Judith Rankin; Anke Rissmann; Catherine Rounding; Annette Queisser-Luft; Gioacchino Scarano; David Tucker
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

4.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

5.  Quantification of selection bias in studies of risk factors for birth defects among livebirths.

Authors:  Dominique Heinke; Janet W Rich-Edwards; Paige L Williams; Sonia Hernandez-Diaz; Marlene Anderka; Sarah C Fisher; Tania A Desrosiers; Gary M Shaw; Paul A Romitti; Mark A Canfield; Mahsa M Yazdy
Journal:  Paediatr Perinat Epidemiol       Date:  2020-04-06       Impact factor: 3.103

6.  Pregnancy, Delivery, and Neonatal Outcomes of In Vitro Fertilization-Embryo Transfer in Patient with Previous Cesarean Scar.

Authors:  Ningyuan Zhang; Hua Chen; Zhipeng Xu; Bin Wang; Haixiang Sun; Yali Hu
Journal:  Med Sci Monit       Date:  2016-09-16

7.  Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening.

Authors:  B Boyle; J K Morris; R McConkey; E Garne; M Loane; M C Addor; M Gatt; M Haeusler; A Latos-Bielenska; N Lelong; R McDonnell; C Mullaney; M O'Mahony; H Dolk
Journal:  BJOG       Date:  2014-02-04       Impact factor: 6.531

8.  Who Should Be Targeted for the Prevention of Birth Defects? A Latent Class Analysis Based on a Large, Population-Based, Cross-Sectional Study in Shaanxi Province, Western China.

Authors:  Zhonghai Zhu; Yue Cheng; Wenfang Yang; Danyang Li; Xue Yang; Danli Liu; Min Zhang; Hong Yan; Lingxia Zeng
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

9.  Dicephalus Parapagus Conjoined Twins Diagnosed by First-Trimester Ultrasound.

Authors:  Keiko Watanabe; Masanori Ono; Mayu Shirahashi; Toshiyuki Ikeda; Kazumi Yakubo
Journal:  Case Rep Obstet Gynecol       Date:  2016-06-05

10.  Increased risk of congenital heart disease in twins in the North of England between 1998 and 2010.

Authors:  K E Best; J Rankin
Journal:  Heart       Date:  2015-09-27       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.